Drugs / 2,6-Diisopropylphenol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03005860 | Jan 2017 → Oct 2020 | breast cancer | Tata Memorial Centre | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2,6-Diisopropylphenol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03005860 ↗ |
| Known as | Propofol | “Intravenous anesthetic, propofol (2,6-diisopropylphenol), is extensively used for general anesthesia without knowing the effects on cancer.” PMID 12127688 ↗ Oct 2002 |